"10.1371_journal.pgen.1001183","plos genetics","2010-10-28T00:00:00Z","Mia M Gaudet; Tomas Kirchhoff; Todd Green; Joseph Vijai; Joshua M Korn; Candace Guiducci; Ayellet V Segrè; Kate McGee; Lesley McGuffog; Christiana Kartsonaki; Jonathan Morrison; Sue Healey; Olga M Sinilnikova; Dominique Stoppa-Lyonnet; Sylvie Mazoyer; Marion Gauthier-Villars; Hagay Sobol; Michel Longy; Marc Frenay; GEMO Study Collaborators; Frans B L Hogervorst; Matti A Rookus; J Margriet Collée; Nicoline Hoogerbrugge; Kees E P van Roozendaal; HEBON Study Collaborators; Marion Piedmonte; Wendy Rubinstein; Stacy Nerenstone; Linda Van Le; Stephanie V Blank; Trinidad Caldés; Miguel de la Hoya; Heli Nevanlinna; Kristiina Aittomäki; Conxi Lazaro; Ignacio Blanco; Adalgeir Arason; Oskar T Johannsson; Rosa B Barkardottir; Peter Devilee; Olofunmilayo I Olopade; Susan L Neuhausen; Xianshu Wang; Zachary S Fredericksen; Paolo Peterlongo; Siranoush Manoukian; Monica Barile; Alessandra Viel; Paolo Radice; Catherine M Phelan; Steven Narod; Gad Rennert; Flavio Lejbkowicz; Anath Flugelman; Irene L Andrulis; Gord Glendon; Hilmi Ozcelik; OCGN; Amanda E Toland; Marco Montagna; Emma D'Andrea; Eitan Friedman; Yael Laitman; Ake Borg; Mary Beattie; Susan J Ramus; Susan M Domchek; Katherine L Nathanson; Tim Rebbeck; Amanda B Spurdle; Xiaoqing Chen; Helene Holland; kConFab; Esther M John; John L Hopper; Saundra S Buys; Mary B Daly; Melissa C Southey; Mary Beth Terry; Nadine Tung; Thomas V Overeem Hansen; Finn C Nielsen; Mark I Greene; Phuong L Mai; Ana Osorio; Mercedes Durán; Raquel Andres; Javier Benítez; Jeffrey N Weitzel; Judy Garber; Ute Hamann; Susan Peock; Margaret Cook; Clare Oliver; Debra Frost; Radka Platte; D Gareth Evans; Fiona Lalloo; Ros Eeles; Louise Izatt; Lisa Walker; Jacqueline Eason; Julian Barwell; Andrew K Godwin; Rita K Schmutzler; Barbara Wappenschmidt; Stefanie Engert; Norbert Arnold; Dorothea Gadzicki; Michael Dean; Bert Gold; Robert J Klein; Fergus J Couch; Georgia Chenevix-Trench; Douglas F Easton; Mark J Daly; Antonis C Antoniou; David M Altshuler; Kenneth Offit","Department of Epidemiology and Population Health and Department of Obstetrics and Gynecology and Womens Health, Albert Einstein College of Medicine, New York, New York, United States of America; Clinical Genetics Service, Department of Medicine, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America; Cancer Biology and Genetics Program, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America; Broad Institute of Harvard and Massachusetts Institute of Technology, Harvard Medical School, Boston, Massachusetts, United States of America; Program in Medical and Population Genetics, Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America; Center for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts, United States of America; Department of Molecular Biology, Massachusetts General Hospital, Boston, Massachusetts, United States of America; Center for Cancer Research, Cancer Inflammation Program, Human Genetics Section, National Cancer Institute – Frederick, Frederick, Maryland, United States of America; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom; Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Centre Hospitalier Universitaire de Lyon/Centre Léon Bérard, Lyon, France; Equipe labellisée LIGUE 2008, UMR5201 CNRS, Centre Léon Bérard, Université de Lyon, Lyon, France; Institut Curie, Service de Génétique, INSERM U830, F-75248, Université Paris Descartes, Paris, France; Service de Genetique Oncologique, Institut Curie, Paris, France; Département Oncologie génétique, Prévention et Dépistage, INSERM CIC-P9502, Institut Paoli-Calmettes/Université dAix-Marseille II, Marseille, France; Institut Bergonié, Bordeaux, France; Centre Antoine Lacassagne, Nice, France; GEMO Study - Cancer Genetics Network Groupe Génétique et Cancer, Fédération Nationale des Centres de Lutte Contre le Cancer, Paris, France; Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Medical Oncology, Rotterdam Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, The Netherlands; Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands; Department of Clinical Genetics, University Medical Center, Maastricht, The Netherlands; Gynecologic Oncology Group Statistical and Data Center, Roswell Park Cancer Institute, Buffalo, New York, United States of America; NorthShore University Health System, Evanston, Illinois, United States of America; Central Connecticut Cancer Consortium, Hartford Hospital, Hartford, Connecticut, United States of America; University of North Carolina, Chapel Hill, North Carolina, United States of America; New York University School of Medicine, New York, New York, United States of America; Molecular Oncology Laboratory, Hospital Clinico San Carlos, Madrid, Spain; Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland; Department of Clinical Genetics, Helsinki University Central Hospital, Helsinki, Finland; Hereditary Cancer Program, Catalan Institute of Oncology, Barcelona, Spain; Department of Oncology, Landspitali–LSH, Reykjavik, Iceland; Department of Pathology, Landspitali–LSH, Reykjavik, Iceland; Faculty of Medicine, University of Iceland, Reykjavik, Iceland; Department of Human Genetics and Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands; Center for Clinical Cancer Genetics and Global Health, Department of Medicine, University of Chicago Medical Center, Chicago, Illinois, United States of America; Department of Population Sciences, the Beckman Research Institute of the City of Hope, Duarte, California, United States of America; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America; Unit of Genetic Susceptibility to Cancer, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy; IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy; Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy; Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia (IEO), Milan, Italy; Division of Experimental Oncology 1, Centro di Riferimento Oncologico (CRO), IRCCS, Aviano (PN), Italy; Moffitt Cancer Center, Tampa, Florida, United States of America; Womens College Research Institute, Toronto, Canada; CHS National Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center, Haifa, Israel; Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Canada; Cancer Care Ontario, Ontario Cancer Genetics Network, University of Toronto, Toronto, Canada; Departments of Molecular Virology, Immunology, and Medical Genetics and Internal Medicine, Ohio State University, Columbus, Ohio, United States of America; Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto, IRCCS, Padua, Italy; Department of Oncology and Surgical Sciences, University of Padua, Padua, Italy; The Susan Levy Gertner Oncogenetics Unit, Institute of Genetics, Sheba Medical Center, Tel Hashomer, Israel; Department of Oncology, Lund University, Lund, Sweden; Division of General Internal Medicine, Department of Medicine, University of California San Francisco, San Francisco, California, United States of America; Gynaecological Oncology Unit, UCL EGA Institute for Womens Health, University College London, United Kingdom; Department of Oncology, The Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America; Department of Cell and Molecular Biology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America; Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America; Genetics and Population Health Division, Queensland Institute of Medical Research, Brisbane, Australia; Peter MacCallum Cancer Centre, Melbourne, Australia; Cancer Prevention Institute of California, Fremont, California, United States of America; Centre for Genetic Epidemiology, University of Melbourne, Melbourne, Australia; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, United States of America; Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America; Centre for Genetic Epidemiology, University of Melbourne, Melbourne, Australia; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, United States of America; Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America; Department of Clinical Biochemistry, Rigshospitalet, Copenhagen University Hospitalet, Copenhagen, Denmark; Clinical Genetics Branch, National Cancer Institute, Rockville, Maryland, United States of America; Human Genetics Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre, Madrid, Spain; Institute of Biology and Molecular Genetics, Universidad de Valladolid (IBGM-UVA), Valladolid, Spain; Oncology Service, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain; Human Genetics Group and Genotyping Unit, Human Cancer Genetics Programme, Spanish National Cancer Research Centre, Madrid, Spain; City of Hope Cancer Center, Duarte, California, United States of America; Dana Farber Cancer Institute, Harvard University, Boston, Massachusetts, United States of America; Molecular Genetics of Breast Cancer, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany; Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom; Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, United Kingdom; Clinical Genetics, Guys and St. Thomas NHS Foundation Trust, London, United Kingdom; Oxford Regional Genetics Service, Churchill Hospital, Oxford, United Kingdom; Nottingham Clinical Genetics Service, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom; Leicestershire Clinical Genetics Service, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom; Womens Cancer Program, Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America; Centre of Familial Breast and Ovarian Cancer, Department of Gynaecology and Obstetrics and Centre for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany; Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum rechts der Isar, Technical University Munich, Munich, Germany; Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Christian-Albrechts University Kiel, Kiel, Germany; Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany; Program in Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America","Conceived and designed the experiments: MD FJC GCT DFE MJD ACA DMA KO. Performed the experiments: TK TG JV JMK CG AVS LM CK JM SH OMS DSL SM MGV HS ML MF GEMO Study Collaborators FBLH MAR JMC NH KEPvR HEBON Study Collaborators MP WR SN LVL SVB TC MdlH HN KA CL IB AA OTJ RBB PD OIO SLN XW ZSF PP SM MB AV PR CMP SN GR FL AF IA GG HO AET MM ED EF YL AB MB SJR SMD KLN TR ABS XC HH kConFab Collaboration EMJ JLH SSB MBD MCS MBT NT TVOH FCN MG PLM AO MD RA JB JNW JG UH SP MC CO DF RP DGE FL RE LI LW JE JB AKG RKS BW SE NA DG KO. Analyzed the data: MMG TK TG KM BG RJK KO. Contributed reagents/materials/analysis tools: TK JV JMK CG AVS LM CK JM SH OMS DSL SM MGV HS ML MF GEMO Study Collaborators FBLH MAR JMC NH KEPvR HEBON Study Collaborators MP WR SN LVL SVB TC MdlH HN KA CL IB AA OTJ RBB PD OIO SLN XW ZSF PP SM MB AV PR CMP SN GR FL AF IA GG HO AET MM ED EF YL AB MB SJR SMD KLN TR ABS XC HH kConFab Collaboration EMJ JLH SSB MBD MCS MBT NT TVOH FCN MG PLM AO MD RA JB JNW JG UH SP MC CO DF RP DGE FL RE LI LW JE JB AKG RKS BW SE NA DG MD BG RJK FJC GCT DFE MJD ACA DMA KO. Wrote the paper: MMG TG JV JMK KM KO.","The authors have declared that no competing interests exist.","2010","10","Mia M Gaudet","MMG",120,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA
